INVESTOR PROFILE

Jeffrey Leiden

Jeffrey Leiden

Jeffrey Leiden

USA

Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals.  Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech. 

Limited Reading

The rest of the content is only available if you are logged in.

Limited Reading
LOG IN
RECOMMENDED
Mohit Goel

Investor

Mohit Goel

India

Astanor Ventures

Investor

Astanor Ventures

Belgium

Ship2B

Investor

Ship2B

Spain

RECOMMENDED

Mohit Goel

Investors

Mohit Goel

India

Astanor Ventures

Investors

Astanor Ventures

Belgium

Ship2B

Investors

Ship2B

Spain

Type in words, phrases, names, etc

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.